Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 18:11:1366062.
doi: 10.3389/fmed.2024.1366062. eCollection 2024.

Methylene blue in sepsis and septic shock: a systematic review and meta-analysis

Raquel Simões Ballarin #  1 , Taline Lazzarin #  1 , Leonardo Zornoff #  1 , Paula Schmidt Azevedo #  1 , Filipe Welson Leal Pereira #  1 , Suzana Erico Tanni #  1 , Marcos Ferreira Minicucci #  1
Affiliations

Methylene blue in sepsis and septic shock: a systematic review and meta-analysis

Raquel Simões Ballarin et al. Front Med (Lausanne). .

Abstract

Background: Methylene blue is an interesting approach in reducing fluid overload and vasoactive drug administration in vasodilatory shock. The inhibition of guanylate cyclase induced by methylene blue infusion reduces nitric oxide production and improves vasoconstriction. This systematic review and meta-analysis aimed to assess the effects of methylene blue administration compared to placebo on the hemodynamic status and clinical outcomes in patients with sepsis and septic shock.

Methods: The authors specifically included randomized controlled trials that compared the use of methylene blue with placebo in adult patients with sepsis and septic shock. The outcomes were length of intensive care unit stay, hemodynamic parameters [vasopressor use], and days on mechanical ventilation. We also evaluated the abnormal levels of methemoglobinemia. This systematic review and meta-analysis were recorded in PROSPERO with the ID CRD42023423470.

Results: During the initial search, a total of 1,014 records were identified, out of which 393 were duplicates. Fourteen citations were selected for detailed reading, and three were selected for inclusion. The studies enrolled 141 patients, with 70 of them in the methylene blue group and 71 of them in the control group. Methylene blue treatment was associated with a lower length of intensive care unit stay (MD -1.58; 95%CI -2.97, -0.20; I2 = 25%; p = 0.03), decreased days on mechanical ventilation (MD -0.72; 95%CI -1.26, -0.17; I2 = 0%; p = 0.010), and a shorter time to vasopressor discontinuation (MD -31.49; 95%CI -46.02, -16.96; I2 = 0%; p < 0.0001). No association was found with methemoglobinemia.

Conclusion: Administering methylene blue to patients with sepsis and septic shock leads to reduced time to vasopressor discontinuation, length of intensive care unit stay, and days on mechanical ventilation.

Systematic review registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023423470, CRD42023423470.

Keywords: meta-analysis; methylene blue; sepsis; septic shock; systematic review.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. MFM declared that he was an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Figures

Figure 1
Figure 1
Flowchart of the article selection process.
Figure 2
Figure 2
Forests plots of time to vasopressor discontinuation, length of ICU stay, and days on mechanical ventilation.
See this image and copyright information in PMC

References

    1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. . The third international consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA. (2016) 315:801–10. doi: 10.1001/jama.2016.0287, PMID: - DOI - PMC - PubMed
    1. Hosseinian L, Weiner M, Levin MA, Fischer GW. Methylene blue: magic bullet for Vasoplegia? Anesth Analg. (2016) 122:194–201. doi: 10.1213/ANE.0000000000001045 - DOI - PubMed
    1. Evans T, Carpenter A, Kinderman H, Cohen J. Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock. (1993) 41:77–81. - PubMed
    1. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. . Early goal-directed therapy in the treatment of severe Sepsis and septic shock. N Engl J Med. (2001) 345:1368–77. doi: 10.1056/NEJMoa010307 - DOI - PubMed
    1. Puntillo F, Giglio M, Pasqualucci A, Brienza N, Paladini A, Varrassi G. Vasopressor-sparing action of methylene blue in severe Sepsis and shock: a narrative review. Adv Ther. (2020) 37:3692–706. doi: 10.1007/s12325-020-01422-x - DOI - PMC - PubMed

Publication types

LinkOut - more resources